Clear Cell Adenocarcinoma — Trials

Clear Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 150
Recruiting: 79
Ph III recruiting: 9
Growth YoY: −15.8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07671417	Imaging Study in Metastatic Clear Cell RCC.	recruiting	Early Phase 1	10	RayzeBio, Inc.INDUSTRY	2	Sep 29, 2026	clinicaltrials
NCT02210117	Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery	active not recruiting	Early Phase 1	104	M.D. Anderson Cancer CenterOTHER	1	Jun 1, 2026	clinicaltrials